Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 4/20 | 0.51 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.51 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.51 |
| ▸ | GLP1R | P43220 | 8/20 | 0.49 |
| ▸ | GHSR | Q92847 | 2/20 | 0.49 |
| ▸ | NPY2R | P49146 | 1/20 | 0.49 |
| ▸ | GCGR | P47871 | 1/20 | 0.48 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31399734 | 0.99 | IL23R (0.51) | IL23RCXCR4C5AR1GLP1RGHSR | |
| SCHEMBL31399727 | 0.97 | CXCR4 (0.53) | IL23RCXCR4GLP1RGCGRNPBWR1 | |
| SCHEMBL31454223 | 0.94 | C5AR1 (0.54) | CXCR4C5AR1GLP1RGHSRNPY2R | |
| SCHEMBL31473234 | 0.92 | NPBWR1 (0.53) | CXCR4C5AR1GLP1RGHSRNPY2R | |
| SCHEMBL31473233 | 0.92 | NPBWR1 (0.53) | CXCR4C5AR1GLP1RGHSRNPY2R | |
| SCHEMBL30590790 | 0.90 | ECE1 (0.53) | GHSR | |
| SCHEMBL29754547 | 0.90 | C5AR1 (0.55) | C5AR1GHSR | |
| SCHEMBL31454225 | 0.90 | GLP1R (0.56) | GLP1RGHSRNPY2RGCGR | |
| SCHEMBL30860218 | 0.90 | PTH1R (0.59) | IL23RGLP1RGHSRNPY2RGCGR | |
| SCHEMBL29461990 | 0.89 | C5AR1 (0.54) | CXCR4C5AR1GLP1RGHSRNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119771358-A | Magnetic composite adsorbent for blood perfusion and preparation method and application thereof | 重庆希尔康血液净化器材研发有限公司 | 2025-04-08 | — | — | CN | disclosed |